Edition:
United States

Perrigo Company PLC (PRGO.N)

PRGO.N on New York Stock Exchange

75.28USD
23 Jun 2017
Change (% chg)

$0.63 (+0.84%)
Prev Close
$74.65
Open
$74.72
Day's High
$75.40
Day's Low
$74.05
Volume
808,117
Avg. Vol
480,624
52-wk High
$99.13
52-wk Low
$65.49

PRGO.N

Chart for PRGO.N

About

Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences and Other. It manufactures OTC... (more)

Overall

Beta: 0.71
Market Cap(Mil.): $10,794.95
Shares Outstanding(Mil.): 143.40
Dividend: 0.16
Yield (%): 0.85

Financials

  PRGO.N Industry Sector
P/E (TTM): -- 14.09 19.01
EPS (TTM): -23.79 -- --
ROI: -23.72 -6.73 -5.03
ROE: -43.21 -6.18 -4.28

BRIEF-Perrigo retains Spencer Stuart for CEO search

* Search process for CEO is being overseen by board's nominating and governance committee Source text for Eikon: Further company coverage:

Jun 21 2017

BRIEF-Perrigo launches generic equivalents to Derma-Smoothe/FS scalp oil and body oil

* Perrigo announces the launch of generic equivalents to Derma-Smoothe/FS scalp oil and body oil Source text for Eikon: Further company coverage:

Jun 21 2017

BRIEF-Perrigo Company announces pricing for its cash tender offer

* Perrigo company plc announces pricing for its cash tender offer

Jun 14 2017

BRIEF-Perrigo Company announces early tender results for cash tender offer

* Perrigo Company Plc announces early tender results for cash tender offer

Jun 14 2017

BRIEF-Perrigo says CEO John Hendrickson's FY 2016 total compensation was $5.8 mln - SEC filing

* Perrigo Company Plc says CEO John Hendrickson's FY 2016 total compensation was $5.8 million - SEC filing

Jun 07 2017

BRIEF-Perrigo Company Plc says CEO John Hendrickson's FY 2016 total compensation was $5.8 million

* Perrigo Company PLC says CEO John Hendrickson's FY 2016 total compensation was $5.8 million

Jun 07 2017

Drugmaker Perrigo's CEO to retire

June 5 Generic drugmaker Perrigo Company Plc said on Monday that Chief Executive John Hendrickson planned to retire.

Jun 05 2017

BRIEF-Perrigo reports forthcoming retirement of CEO Hendrickson

* Perrigo announces forthcoming retirement of CEO John Hendrickson

Jun 05 2017

BRIEF-Perrigo Company announces $1.4 bln cash tender offer for certain notes

* Perrigo Company Plc announces $1,400,000,000 cash tender offer for certain notes

May 31 2017

BRIEF-Perrigo Company reaffirms FY17 adj EPS view $4.15 to $4.50

* Perrigo Company PLC files first quarter 2017 form 10-Q and reports first quarter 2017 financial results

May 30 2017

More From Around the Web

Earnings vs. Estimates